Oncology Clinical Trial Trends in the US
FDA questions efficacy of Amgen’s Lumakras in lung cancer trial
The outcomes have given rise to inquiries regarding the clinical relevance of the confirmatory trial.
The outcomes have given rise to inquiries regarding the clinical relevance of the confirmatory trial.